Inappropriate dental antibiotic prescriptions to prevent infective endocarditis in the United States results in ∼$31 million in excess costs to the healthcare system and patients. This includes out-of-pocket costs ($20.5 million), drug costs ($2.69 million) and adverse event costs (eg, and hypersensitivity) of $5.82 million (amoxicillin), $1.99 million (clindamycin), and $380,849 (cephalexin).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1017/ice.2023.126 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!